Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic.

Article Details

Citation Copy to clipboard

Torphy TJ, Barnette MS, Underwood DC, Griswold DE, Christensen SB, Murdoch RD, Nieman RB, Compton CH

Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic.

Pulm Pharmacol Ther. 1999;12(2):131-5.

PubMed ID

10373396 [ View in PubMed

]

Abstract

Not Available